| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00007890-200011270-00023 |
| P698 | PubMed publication ID | 11118102 |
| P50 | author | Marcelo A. Fernández-Viña | Q59750308 |
| P2093 | author name string | M Fox | |
| J S Wilson | |||
| B Philosophe | |||
| S T Bartlett | |||
| M Gutierrez | |||
| J Hunter | |||
| J Colonna | |||
| B E Jarrell | |||
| E J Schweitzer | |||
| A Wiland | |||
| A Farney | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1531-1536 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants | |
| P478 | volume | 70 |
| Q36063312 | A case of desensitization, transplantation, and allograft dysfunction |
| Q44077744 | ABO-incompatible kidney transplantation using both A2 and non-A2 living donors |
| Q44895122 | Acute renal transplant injury and interaction between antithymocyte globulin and pooled human immunoglobulin |
| Q36736625 | Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies |
| Q37676032 | Advances in diagnosing and managing antibody-mediated rejection |
| Q33415207 | Anti-HLA alloantibodies in surgical patients refractory to platelet transfusion |
| Q41910625 | Anti-Leb (Lewis) antibody in renal transplantation, emphasizing the role of transfusion medicine in organ transplantation |
| Q33414196 | Antibody desensitization therapy in highly sensitized lung transplant candidates. |
| Q47869308 | Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection |
| Q37332696 | Antibody-mediated rejection: treatment alternatives and outcomes. |
| Q37820338 | Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach |
| Q59305672 | Can intravenous immunoglobulin and simvastatin solve the problem of sensitization in renal transplant candidates? |
| Q73500046 | Cardiac transplantation across a positive prospective lymphocyte cross-match in sensitized recipients |
| Q38050751 | Clinical applications of immunoglobulin: update |
| Q40373480 | Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study. |
| Q74815832 | Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg) |
| Q39718404 | Early but not late allograft nephrectomy reduces allosensitization after transplant failure |
| Q85485720 | Effects of mycophenolic acid on highly sensitized patients awaiting kidney transplant |
| Q46452614 | Highly successful living donor kidney transplantation after conversion to negative of a previously positive flow-cytometry cross-match by pretransplant plasmapheresis |
| Q44618296 | Hyperimmunized patients awaiting cadaveric kidney graft: is there a quick desensitization possible? |
| Q27023312 | Issues in solid-organ transplantation in children: translational research from bench to bedside. |
| Q39173951 | Kidney paired exchange and desensitization: Strategies to transplant the difficult to match kidney patients with living donors |
| Q37078175 | Kidney transplantation in sensitized recipients; a single center experience |
| Q46874561 | Late developing C4d-positive humoral renal allograft rejection associated with withdrawal of mycophenolate mofetil |
| Q34360517 | Managing the highly sensitized transplant recipient and B cell tolerance |
| Q55036659 | Overcoming a positive crossmatch in living-donor kidney transplantation. |
| Q79285293 | Plasmapheresis in renal transplant patients: a single-center experience |
| Q78039969 | Relationship between patients' perceptions of disadvantage and discrimination and listing for kidney transplantation |
| Q92574914 | Renal Transplantation in High Immunological Risk Patients: A Single-Center Experience |
| Q36895544 | Renal transplantation in high-risk patients |
| Q35564385 | Renal transplantation: Basic concepts and evolution of therapy |
| Q37710374 | Sensitized renal transplant recipients: current protocols and future directions |
| Q53388671 | Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience. |
| Q37078119 | Successful renal transplantation with desensitization in highly sensitized patients: a single center experience |
| Q36827985 | Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. |
| Q39254100 | The effect of histopathologic and clinical features on allograft survival in renal transplant patients with antibody-mediated rejection |
| Q60998166 | The impact of allograft nephrectomy on percent panel reactive antibody and clinical outcome |
| Q35583534 | The role of B cells and alloantibody in the host response to human organ allografts |
| Q26778752 | Translational research in kidney transplantation and the role of patient engagement |
| Q27021397 | Treatment options and strategies for antibody mediated rejection after renal transplantation |
| Q79979170 | [Alloantibodies-mediated kidney transplant rejection: a pair of continuing approaches, and with nonetheless many open questions] |
Search more.